<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for SB 2539         </title>
<shortdesc>CONTROLLED SUBSTANCE-PRESCRIBE</shortdesc>
<sponsor>
<sponsorhead1>Senate Sponsors</sponsorhead1><sponsors>Sen. Don Harmon</sponsors>
</sponsor>
<lastaction>
<statusdate>1/10/2023</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>720 ILCS 570/322 new</reference><aliasreference></aliasreference><SynopsisText>Amends the Illinois Controlled Substances Act. Provides that a prescriber shall offer a prescription for naloxone hydrochloride, or another similar drug approved by the Food and Drug Administration, under specified circumstances. Provides for educational information to be provided concerning overdose prevention and the use of naloxone hydrochloride. Provides that a prescriber who does not comply with specified requirements shall be subject to administrative sanctions under the appropriate licensing board. Specifies that the provisions do not create a private right of action against a prescriber, and do not limit a prescriber's liability for the negligent failure to diagnose or treat a patient. Provides that these provisions do apply to a patient receiving hospice care in accordance with the Hospice Program Licensing Act. Contains a purpose provision. Effective immediately.</SynopsisText></synopsis>
<actions>
<statusdate>2/26/2021</statusdate><chamber>Senate</chamber><action>Filed with Secretary by Sen. Melinda Bush</action>
<statusdate>2/26/2021</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>2/26/2021</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
<statusdate>12/31/2022</statusdate><chamber>Senate</chamber><action>Chief Sponsor Changed to Sen. Don Harmon</action>
<statusdate>1/10/2023</statusdate><chamber>Senate</chamber><action>Session Sine Die</action>
</actions>
</xml>

